Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
November 22, 2022
Patent Application Number
16612352
Date Filed
May 8, 2018
Patent Citations
Patent Primary Examiner
Disclosed herein are alphavirus vectors that include neoantigen-encoding nucleic acid sequences derived from a tumor of a subject. Also disclosed are nucleotides, cells, and methods associated with the vectors including their use as vaccines.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
